David Supple, MD, explains why the Penn Heart & Vascular electrophysiology program is a leading referral center for the extraction of implantable cardioverter defibrillator leads and discusses ongoing research at Penn focusing on the development of leadless ICDs to preclude the risks associated with lead extraction.
Related Links
- View Outcomes Report: The Future of Electrophysiology
- View Clinical Program: Device Lead Extraction Expertise at the Cardiac Arrhythmia Program
- View Dr. Supple's Profile
Published
May 9, 2014
Created by
BROADCASTMED